Severe acute respiratory syndrome (SARS) - An emerging infection of the 21st century

Journal of the Formosan Medical Association

Volumn 102, Issue 12, 2003, Pages 825-839

  Hsueh, Po Ren ^a   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Disease transmission; Infection control; Review; SARS virus; Taiwan

Indexed keywords

ANTIVIRUS AGENT; AZAURIDINE; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CORTICOSTEROID; GAMMA INTERFERON; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; L 700417; LOPINAVIR PLUS RITONAVIR; MACROLIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PIRAZOFURIN; PROTEINASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; VIRUS ANTIBODY; VIRUS VACCINE;

AEROSOL; BLOOD ANALYSIS; CHILD CARE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG POTENTIATION; DYSPNEA; EARLY DIAGNOSIS; EPIDEMIC; FEVER; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HISTOPATHOLOGY; HOUSEHOLD; HUMAN; HYPOXIA; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INFECTION CONTROL; LEGIONELLA PNEUMOPHILA; MEDICAL RESEARCH; MORTALITY; MYCOPLASMA PNEUMONIAE; NONHUMAN; NOSE SMEAR; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATIENT CARE; PHYSICIAN; PNEUMONIA; POLYMERASE CHAIN REACTION; RELIABILITY; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOM; THORAX RADIOGRAPHY; THROAT CULTURE; VIRUS TRANSMISSION;

COMMUNICABLE DISEASES, EMERGING; HUMANS; SEVERE ACUTE RESPIRATORY SYNDROME; TAIWAN;

EID: 2342561924     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Lee N, Hui D, Wu A, et al: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986-94.
2. Tsang KW, Ho PL, Ooi GC, et al: A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1977-85.
3. Poutanen SM, Low DE, Henry B, et al: Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348: 1995-2005.
4. Booth CM, Matukas LM, Tomlinson GA, et al: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801-9.
5. Hsu LY, Lee CC, Green JA, et al: Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003;9:713-7.
6. Lee ML, Chen CJ, Su IJ, et al: Severe acute respiratory syndrome- Taiwan, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 461-6.
7. Twu SJ, Chen TJ, Chen CJ, et al: Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 2003;9:718-20.
8. Hsueh PR, Hsiao CH, Yeh SH, et al: Microbiologic characteristics, serologic response, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003;9:1163-7.
9. Singh K, Hsu LY, Villacian JS, et al: Severe acute respiratory syndrome: lessons from Singapore. Emerg Infect Dis 2003;9: 1294-8.
10. Oh VM, Lim TK: Singapore's experience of SARS. Clin Med 2003; 3:448-51.
11. Ksiazek TG, Erdman D, Goldsmith C, et al: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
12. Drosten C, Gunther S, Preiser W, et al: identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
13. Peiris JSM, Lai ST, Poon LLM, et al: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361: 1319-25.
14. Fouchier RAM, Kuiken T, Schutten M, et al: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
15. Chan PKS, Tam JS, Lam CW et al: Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1058-63.
16. Peiris JSM, Chu CM, Cheng VCC, et al: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361; 1767-72.
17. Abdullah ASM, Tomlinson B, Cockram CS, et al: Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 2003;9:1042-5.
18. Carolyn F, Karen B: Responding to the severe acute respiratory syndrome (SARS) outbreak: lessons learned in a Toronto emergency department. J Emerg Nurs 2003;29:222-8.
19. Seto WH, Tsang D, Yung RW, et al: Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome. Lancet 2003; 361:1519-20.
20. Lipsitch M, Cohen T, Cooper R, et al: Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300: 1966-70.
21. Zhou G, Yan G: Severe acute respiratory syndrome in Asia. Emerg Infect Dis. In press 2003.
22. Manocha S, Walley KR, Russell JA: Severe acute respiratory syndrome (SARS): a critical care perspective. Crit Care Med 2003; 31:2684-92.
23. Nie QH, Luo XD, Zhang JZ: Current status of severe acute respiratory syndrome in China. World J Gastroenterol 2003;9: 1635-45.
24. Severe Acute Respiratory Syndrome (SARS): summary table of SARS cases by country, 1 November 2002 [accessed September 26, 2003]. Available from: URL: http://www.who.int/csr/sars/country/table2003_09_23/en
25. Lim HK, Liu CP, Huang FY, et al: Severe acute respiratory syndrome in a medical center in Taipei. J Microbiol Immunol Infect 2003;36:161-8.
26. Wong WW, Chen TL, Yang SP, et al: Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei. J Chin Med Assoc 2003;66:323-7.
27. Chiang CH, Chen HM, Shih JF, et al: Management of hospital-acquired severe acute respiratory syndrome with different disease spectrum. J Chin Med Assoc 2003;66;328-38.
28. Hsueh PR, Chen PJ, Hsiao CH, et al: Clinical features, pathological findings, and cytokine response among patients with severe acute respiratory syndrome in Taiwan at the beginning of the epidemic. Emerg Infect Dis. In press 2004.
29. Wang JT, Sheng WH, Fang CT, et al: Clinical pictures, temporal progression of laboratory findings, and treatment outcome of patients of probable severe acute respiratory syndrome. Emerg Infect Dis. In press 2004.
30. Center for Disease Control, Department of Health, Executive Yuan, Taiwan: Memoir of severe acute respiratory syndrome control in Taiwan. 2003. Available from: URL: http://www.cdc.gov.tw
31. World Health Organization: WHO SARS Scientific Research Advisory Committee concludes its first meeting. Geneva: 22 October 2003. Available from: URL: http://www.who.int/csr/sars/achieve/research/en/
32. Tsang KW, Lam WK: Management of severe acute respiratory syndrome. The Hong Kong University experience. Am J Respir Crit Care Med 2003;168:417-24.
33. Hawkey PM, Bhagani S, Gillespie SH: Severe acute respiratory syndrome (SARS): breathtaking progress. J Med Microbiol 2003; 52:609-13.
34. Groneberg DA, Zhang I, Welte T, et al: Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 2003; 96:845-52.
35. Hong T, Wang JW, Sun YL, et al: Chlamydia-like and coronavirus-like agents found in dead cases of atypical pneumonia by electron microscopy. Zhonghua Yi Xue Za Zhi 2003;83:632-6.
36. Kuiken T, Fouchier RA, Schutten M, et al: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263-70.
37. Pene F, Merlat A, Vabret A, et al: Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis 2003;37:929-32.
38. Marra MA, Jones SJM, Astell CR, et al: The genome sequence of the SARS-associated coronavirus. Science 2003;300: 1399-404.
39. Rota PA, Oberste MS, Monroe S, et al: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
40. Li L, Wang Z, Lu Y, et al: Severe acute respiratory syndrome-associated coronavirus genotype and its characterization. Chin Med J (Engl) 2003;116:1288-92.
41. Tsui SKW, Chim SSC, Lo YMD: Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. Lancet 2003;349:187-8.
42. Chiu RW, Chim SS, Lo YM: Molecular epidemiology of SARS-from Amoy Gardens to Taiwan. N Engl J Med 2003;349; 1875-6.
43. Zhong NS, Zheng BJ, Li YM, et al: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003. Lancet 2003;362:1353-8.
44. Guan Y, Zheng BJ, He YQ, et al: Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276-8.
45. Martina BEE, Haagmans BL, Kuiken T, et al: SARS virus infection of cats and ferrets. Nature 2003;425:915.
46. Centers for Disease Control and Prevention (CDC): Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep 2003;52:986-7.
47. Enserink M: Clues to the animal origins of SARS. Science 2003; 300:1351.
48. Enserink M, Normile D: Search for SARS origins stalls. Science 2003;302:766-7.
49. Tsang OTY, Chau TN, Choi KW, et al: Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis 2003;9:1381-7.
50. Ng SK: Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet 2003;362:570-2.
51. Leung WK, To KF, Chan PKS, et al: Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003;125:1011-7.
52. World Health Organization: Case definition for surveillance of severe acute respiratory syndrome (SARS). Geneva: 1 May 2003. Available from: URL: http://www.who.int/csr/sars/casedefinition/en
53. Updated interim U.S. case definition for severe acute respiratory syndrome (SARS). Available from: URL: http://www.cdc.gov/ncidod/sars/pdf/sars-casedefinition.pdf
54. Wang JT, Wang JL, Fang CT, et al: Temporary defervescence in the first week of disease course does not indicate recovery of disease in a patient with severe acute respiratory syndrome. Emerg Infect Dis. In press 2004.
55. Wang JL, Wang JT, Yu CJ, et al; Rhabdomyolysis associated with probable SARS. Am J Med 2003;115:421-2.
56. Chan PKS, Ip M, Ng KC, et al: Severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003;9:1453-4.
57. Lee HKK, Tso EYK, Chau TN, et al: Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis 2003;9:1491-2.
58. Li G, Zhao Z, Chan L, Zhou Y: Mild severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1182-3.
59. Wong R, Wu A, To KF, et al: Heamatological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326:1358-62.
60. Cui W, Fan Y, Wu W, et al: Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin Infect Dis 2003;37:857-9.
61. Choi KW, Chau TN, Tsang O, et al: Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003; 139: 715-23.
62. Wong PN, Mak SK, Lo KY: Clinical presentation and outcome of severe acute respiratory syndrome. Am J Kidney Dis 2003; 42:1075-81.
63. Kwan BC, Leung CB, Szeto CC, et al: Severe acute respiratory syndrome in a hemodialysis patient. Am J Kidney Dis 2003;42: 1069-74.
64. Beijing Group of National Research Project for SARS: Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin Med J (Engl) 2003;116:1283-7.
65. Glass WG, Rosenberg HF, Murphy PM: Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol 2003;3:467-73.
66. Poon LL, Chan KH, Wong OK, et al: Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 2003;28: 233-8.
67. Yam WC, Chan KH, Poon LLM, et al: Evaluation of reverse transcription-PCR assay for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol 2003;41:4521-4.
68. Li G, Chen X, Xu A: Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 2003;349:508-9.
69. Mazzulli T, Farcas GA, Poutanen SM, et al: Severe acute respiratory syndrome-associated coronavirus in lung tissue. Available from: URL: http://www.cdc.gov/ncidod/EID/vol10no1/03-0404.htm
70. Rainier TH, Cameron PA, Smit D, et al: Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ 2003;326: 1354-8.
71. Muller NL, Ooi GC, Khong PL, et al: Severe acute respiratory syndrome: radiological and CT findings. AJR Am J Roentgenol 2003;181:3-8.
72. Ooi CG, Khong PL, Ho JC, et al: Severe acute respiratory syndrome: radiographic evaluation and clinical outcome measures. Radiology 2003;229:500-6.
73. Wong KT, Antonio GE, Hui DSC, et al: Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology 2003;228:395-40.
74. Wong KT, Antonio GE, Hui DSC, et al: Severe acute respiratory syndrome: radiologic appearances and pattern of progression in 138 patients. Radiology 2003;228:401-6.
75. Franks TJ, Chong PY, Chui P, et al: Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 2003;34:743-8.
76. Nicholls JM, Poon LL, Lee KC, et al: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773-8.
77. Ding Y, Wang H, Shen H, et al: The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003;200:282-9.
78. Ho JC, Ooi GC, Mok TY, et al: High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003 Aug 28 [Epub ahead of print].
79. So LKY, Lau ACW, Yam LYC, et al: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615-6.
80. Wong VWS, Dai D, Wu AKL, et al: Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003;9:199-201.
81. Huggins J: USAMRIID-NIAID-CDC in vitro antiviral SARS-CoV testing program. National Institute of Allergy and Infectious Diseases, USA, May 2003. Available from: URL: http://SARSreference.com/link.php?id=21
82. Wang HJ, Ding YQ, Li X, et al: Fatal aspergillosis in a patient with SARS who was treated wigh corticosteroids. N Engl J Med 2003;349:507-8.
83. Sewell WAC, Jolles S: Immunomodulatory action of intravenous immunoglobulin. Immunology 2002;107:387-93.
84. Moriguchi H, Sato C: Treatment of SARS with human interferons. Lancet 2003;362:1159.
85. Cinatl J, Chandra P, Rabenan H, et al: Treatment of SARS with human interferons. Lancet 2003;362:1158-9.
86. Cinatl J, Morgenstern B, Bauer G, et al: Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003;361:2045-6.
87. Anand K, Ziebuhr J, Wadhwani P, et al: Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003;300:1763-7.
88. Jenwitheesuk E, Samudrala R: Identifying inhibitors of the SARS coronavirus proteinases. Bioorg Med Chem Lett 2003;17: 3989-92.
89. Hon KLE, Leung CW, Cheng WTF, et al: Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-3.
90. Chiu WK, Cheung PCH, Ng KL: Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med 2003;4:279-83.
91. Bitnun A, Allen U, Heurter H, et al: Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003;112:e261.
92. Shek CC, Ng PC, Fung GPG, et al: Infants born to mothers with severe acute respiratory syndrome. Pediatrics 2003;112:e254.
93. Sit SC, Yau EKC, Lam YY, et al: A young infant with severe acute respiratory syndrome. Pediatrics 2003;112:e257.
94. Senior K: Recent Singapore SARS case a laboratory accident. Lancet Infect Dis 2003;3:679.
95. Centers for Disease Control and Prevention (CDC): Use of quarantine to prevent transmission of severe acute respiratory syndrome-Taiwan, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:680-3.
96. Centers for Disease Control and Prevention (CDC): Efficacy of quarantine during an epidemic of severe acute respiratory syndrome-Beijing, China, 2003. MMWR Morb Mortal Wkly Rep 2003;52:1037-40.
97. Chiu YT: Taiwanese scientists find genetic link to SARS. Nat Med 2003;9:1335.
98. Chen SY, Su CP, Ma MHM, et al: Predictive model of diagnosing cases of severe acute respiratory syndrome (SARS) in febrile patients with exposure risk. Ann Emerg Med. In press 2004.
99. Su CP, Chiang WC, Ma MHM, et al: Validation of a novel SARS scoring system. Ann Emerg Med. In press 2004.
100. Cyranoski D: Taiwan left isolated in fight against SARS. Nature 2003;17:652.